Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.780 | 0.780 | 0.000 |
Stocks | 97.340 | 97.340 | 0.000 |
Bonds | 1.890 | 1.890 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.611 | 16.425 |
Price to Book | 4.175 | 2.546 |
Price to Sales | 3.210 | 1.985 |
Price to Cash Flow | 15.761 | 11.717 |
Dividend Yield | 1.407 | 2.288 |
5 Years Earnings Growth | 12.382 | 11.364 |
Name | Net % | Category Average |
---|---|---|
Technology | 27.120 | 20.089 |
Financial Services | 16.440 | 17.192 |
Healthcare | 14.280 | 11.281 |
Industrials | 11.340 | 19.176 |
Consumer Cyclical | 9.930 | 8.642 |
Consumer Defensive | 7.280 | 5.414 |
Communication Services | 6.540 | 6.738 |
Basic Materials | 3.790 | 3.984 |
Real Estate | 2.090 | 5.136 |
Utilities | 1.190 | 3.042 |
Number of long holdings: 70
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Taiwan Semiconductor | US8740391003 | 4.65 | 183.80 | -0.69% | |
Microsoft | US5949181045 | 4.63 | 427.99 | +2.20% | |
NVIDIA | US67066G1040 | 4.39 | 136.92 | +0.66% | |
Apple | US0378331005 | 3.73 | 234.97 | +0.90% | |
Trane Technologies | IE00BK9ZQ967 | 3.32 | 419.14 | +1.41% | |
UnitedHealth | US91324P1021 | 3.23 | 606.10 | +0.04% | |
AbbVie | US00287Y1091 | 3.21 | 181.14 | +2.30% | |
Roche Holding Participation | CH0012032048 | 2.99 | 251.40 | -0.83% | |
RBC | CA7800871021 | 2.98 | 124.15 | -0.14% | |
S&P Global | US78409V1044 | 2.91 | 521.99 | +0.46% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Naventi Balanserad Flex | 4.97B | 14.35 | 0.87 | 6.25 | ||
Naventi Defensiv Flex | 1.01B | 10.26 | 1.57 | 3.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review